School Of Medicine Basic Sciences

Christina Termini, a University of California President’s Postdoctoral Fellow at UCLA, will discuss “Leveraging Proteoglycans for Hematopoietic Stem Cell Regeneration” on Tuesday, Dec. 8, beginning at 4 p.m. CT via Zoom. Read More

The Vanderbilt School of Medicine Basic Sciences has won continued funding from the National Institutes of Health for its Initiative for Maximizing Student Diversity program supporting the success of biomedical graduate students from underrepresented backgrounds. Read More

Read about the latest faculty, staff and student awards, appointments and achievements. Read More

Further research by biochemistry professors Charles Sanders and  Bruce Carter into therapeutics for Charcot-Marie-Tooth disease, an inherited condition that damages peripheral nerves, will be funded by Ancora Innovation LLC, a Deerfield Management company that supports Vanderbilt’s innovative life science research. Read More

Vanderbilt biochemists figure out how the little-understood Envelope protein helps SARS-CoV-2 function and how to disrupt the endogenously creative virus. Read More

Vanderbilt contributes molecular imaging data of kidney to the Human BioMolecular Atlas Program, a consortium of 18 diverse collaborative research teams across the United States and Europe. Read More

Vanderbilt researchers have identified a new molecular partner — and potential therapeutic target — in a signaling axis that drives lung cancer. Read More

Erin Calipari, assistant professor of pharmacology and of psychiatry and behavioral sciences, discusses the COVID-19 pandemic's impact on those struggling with opioid addiction. Read More

Yi Ren, assistant professor of biochemistry, has contributed to research on the function and impact of the SARS-CoV-2 protein on immune signaling protein in host cells. This understanding may lead to the development of immune-enhancing therapeutics.  Read More

Cornelius Taabazuing, a postdoctoral fellow at the Memorial Sloan-Kettering Cancer Center, will present “Investigating the molecular regulation and function of death signaling complexes.” The Discovery Science Emerging Scholars Lecture is scheduled for Thursday, Nov. 19, at 9:30 a.m. via Zoom. Read More

Assistant Professor of Biochemistry Yi Ren and her team have made several discoveries to illuminate the mechanisms of key host-pathogen interactions involving viruses, with implications for gaining a better understanding of SARS-CoV-2, the virus that causes COVID-19. Read More

Nancy Carrasco, professor and chair of the Department of Molecular Physiology and Biophysics and the Joe C. Davis Chair of Biomedical Science, receives one of the highest honors in health and medicine. Read More

Vanderbilt researchers discover how a group of neurodevelopmental disorders ranging in severity are caused in infants and children, opening new avenues for therapeutics. Read More

Behavioral and systems neuropharmacologist Jerri Rook is recognized by the Alzheimer’s Drug Discovery Foundation with the Goodes Prize to continue her work in Alzheimer’s disease research. Read More

Histamine — commonly associated with allergies — also has a signaling role in the brain’s reward center and may offer a novel target for treating addiction. Read More

Jacek Hawiger’s anti-inflammatory peptide therapy, licensed by Amytrx and now in clinical trials, has the potential to safely and effectively treat a multitude of inflammatory and metabolic diseases. Read More

Vanderbilt researchers—including Charles Sanders, associate dean for research and professor of biochemistry, and graduate student Justin Marinko—have illuminated the cause of Charcot-Marie-Tooth disease, putting them on the road to developing therapeutic approaches for the disease that affects one in 2,500 people. Read More

New Assistant Professor of Pharmacology Rick Sando is interested in how neural circuits carry out specific functions when activated—and why these processes sometimes go awry. Read More

Drug-tolerant persister cells–those that survive cancer treatment–found to rely on similar survival mechanisms across cancers, in a groundbreaking study led by Vanderbilt researchers. Read More

Craig Lindsley, the William K. Warren, Jr. Chair and University Professor of Pharmacology, Biochemistry and Chemistry, will become director of Vanderbilt University’s Warren Center for Neuroscience Drug Discovery, effective Dec. 1, 2020. Read More